Clinicopathological study of gall bladder carcinoma: Our experience from Patan Hospital, Patan academy of health sciences
AbstractIntroduction: Gall bladder carcinoma is not a common disease. The overall prevalence is low worldwide. It is a highly malignant tumor with a poor prognosis. The outcome of gallbladder carcinoma is poor, and the overall 5-year survival rate is less than 5%. The carcinoma gall bladder is 2-6 times more common in females compared to males and its incidence increases with increasing age. Aggressive surgical management and preoperative adjuvant therapy have helped to prolong survival in patients with gallbladder cancer. We conducted a study with an aim to evaluate the clinicopathological aspect of the disease in patients of gall bladder cancer managed in our surgical department.
Methods: Data were recorded retrospectively by reviewing the charts of the patients who were diagnosed and treated for carcinoma gall bladder in Patan hospital from Aug 2017 To Aug 2019.
Results: Thirty patients were included in the study. Twenty (66.7%) were female and ten (33.33%) were males. Age ranged from 36 to 83 years with the median age of presentation at 63.5 yrs. Curative treatment was possible in 43.33% of the patient, among them 12 had radical surgery and one had cholecystectomy alone for the T1a stage. All other (56.6%) required palliative treatment. One patient developed liver metastasis within six months of radical excision.
Conclusions: The majority of the patients present with an advanced disease which makes it less chance for curative surgical resection. Since only palliative care is possible in an advanced stage, early detection and curative treatment are advisable.
2. Goetze TO, Paolucci V. Adequate extent in radical re-resection of incidental gallbladder carcinoma: Analysis of the German Registry. Surg Endosc. 2010 Sep;24(9):2156-64.
3. Hundal R, Shaffer EA. Gallbladder cancer: Epidemiology and outcome. Clin Epidemiol. 2014 Mar 7;6:99-109.
4. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015 Nov 21;21(43):12211-7.
5. Mishra R, Goda C, Arora M, Sood M, Siddiqui AA, Husain A, et al. Treatment of Gall Bladder Cancer: A Review. Indo Glob J Pharm Sci. 2012 Mar;2(1):54–62.
6. Tyagi B, Manoharan N, Raina V. Risk factors for gallbladder cancer?: A population based case-control study in Delhi. Indian J Med Paediatr Oncol. 2008;29(1):16-26.
7. Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev. 2003 Aug;12(4):269-72.
8. Roa JC, Tapia O, Cakir A, Basturk O, Dursun N, Akdemir D, et al. Squamous cell and adenosquamous carcinomas of the gallbladder: Clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol [Internet]. 2011;24(8):1069–78. Available from: http://dx.doi.org/10.1038/modpathol.2011.68
9. Varshney S, Buttirini G, Gupta R. Incidental carcinoma of the gallbladder. European Journal of Surgical Oncology (EJSO). 2002 Feb;28(1):4-10.
10. Toyonaga T, Chijiiwa K, Nakano K, Noshiro H, Yamaguchi K, Sada M, et al. Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg. 2003 Mar;27(3):266–71.
11. Ghimire P, Yogi N, Shrestha BB. Incidence of incidental carcinoma gall bladder in cases of routine cholecystectomy. Kathmandu Univ Med J. 2011 Apr-Jun;9(34):3–6.
12. Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: A review. J Gastrointest Surg. 2007 Sep;11(9):1188-93.
13. Khan RA, Wahab S, Khan MA, Siddiqui S, Maheshwari V. Advanced presentation of Gallbladder cancer: Epidemioclinicopathological study to evaluate the risk factors and assess the outcome. J Pak Med Assoc. 2010 Mar;60(3):217-9.
14. di Le M, Henson D, Young H, Albores-Saavedra J. Is gallbladder cancer decreasing in view of increasing laparoscopic cholecystectomy? Ann Hepatol. 2011 Jul;10(3):306–14.
15. Shukla VK, Khandelwal C, Roy SK, Vaidya MP. Primary carcinoma of the gall bladder: A review of a 16?year period at the university hospital. J Surg Oncol. 1985 Jan;28(1):32-5.
16. Hamdanil NH, Qadri SK, Aggarwalla R, Bhartia VK, Chaudhuri sumit, Debakshi S, et al. Clinicopathological study of gall bladder carcinoma with special reference to gallstones: Our 8-year experience from eastern India. Asian Pac J Cancer Prev. 2012;13(11):5613-7.
17. Gupta A, Gupta S, Chauhan U, Kumar U, Sharma N, Ahuja R, et al. Symptom palliation in advanced gallbladder cancer: An institutional experience. Indian J Palliat Care. 2019 Oct-Dec;25(4):514-6.
18. Jha V, Sharma P, Mandal Ka. Incidental gallbladder carcinoma: Utility of histopathological evaluation of routine cholecystectomy specimens. South Asian J Cancer. 2018 Jan-Mar;7(1):21-23.
19. Iwama A, Yamazaki S, Mitsuka Y, Yoshida N, Moriguchi M, Higaki T, et al. Clinical Study A Longitudinal Computed Tomography Imaging in the Diagnosis of Gallbladder Cancer. Gastroenterology Research and Practice. 2015, Article ID 254156, 7 pages. Available from: http://dx.doi.org/10.1155/2015/254156
20. Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol. 2014 Apr 14;20(14):4085-92.
21. Hong EK, Kim KK, Lee JN, Lee WK, Chung M, Kim YS, et al. Surgical outcome and prognostic factors in patients with gallbladder carcinoma. Korean J Hepatobiliary Pancreat Surg. 2014 Nov;18(4):129-37.
22. Shibata K, Uchida H, Iwaki K, Kai S, Ohta M, Kitano S. Lymphatic invasion: An important prognostic factor for stages T1b-T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer. World J Surg. 2009 May;33(5):1035-41.
23. Yamaguchi R, Nagino M, Oda K, Kamiya J, Uesaka K, Nimura Y. Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg. 2002 Sep;89(9):1130-6.
24. Ito H, Ito K, D’Angelica M, Gonen M, Klimstra D, Allen P, et al. Accurate staging for gallbladder cancer: Implications for surgical therapy and pathological assessment. Ann Surg. 2011 Aug;254(2):320-5.
25. Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB. 2016 Nov 1;18(11):872–8.
26. Hassan MAM, Wongjarupong N, Sanhueza CT, Hartgers ML, Hassan F, Roberts LR, et al. Role of adjuvant therapy in resected gallbladder cancer. J Clin Oncol. 2018 Feb;36(4_suppl):452–452.
27. Kim TH, Woo SM, Lee WJ, Oh ES, Youn SH, Moon SH, et al. Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma. Sci Rep. 2019 Dec 1;9(1).
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
JSSN applies the Creative Commons Attribution (CC BY) license to all works we publish. Under the CC BY license, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, distribute, and/or copy articles in JSSN, so long as the original authors and source are cited. No permission is required from the authors or the publishers.
Article by JSSN is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://www.jssn.org.np/index.php?journal=jssn.